P15-21. Investigating the utility and relevance of the good participatory practice guidelines for biomedical HIV prevention trials by Feuer C, Grant D, Fisher K, Warren M, Bass E, Miller L

P15-15. Advocates' perspectives on community engagement in the HVTN 505 by Miller L, Grant D, Fisher K, Feuer C, Bass E, Warren M

P15-03. HIV vaccine funding trends entering a global recession: research and development (R&D) from 2000 – 2008 by Vuthoori S, Romero L, Lee W, Harrison P, Feuer C, Fisher K, Warren M